Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) announced it has received a $15 million milestone payment from development and commercialization partner Braeburn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE